PRACTICE GAPS AND BARRIERS TO OPTIMAL MANAGEMENT OF MULTIPLE MYELOMA PATIENTS : RESULTS FROM A MIXED-METHODS STUDY IN 8 EUROPEAN COUNTRIES.

EHA Library, Mohamad Mohty, 182674

THE EXPRESSION OF APRIL BY MULTIPLE MYELOMA CELLS AND THEIR ROLE IN THE EVOLUTION OF MULTIPLE MYELOMA

EHA Library, Peggy Kanellou, 182675

DEVELOPMENT OF SECOND PRIMARY MALIGNANCY AFTER TREATMENT WITH LENALIDOMIDE: A SINGLE CENTRE EXPERIENCE.

EHA Library, Fergal McGlynn, 182676

SOLITARY PLASMACYTOMA. A SINGLE-CENTRE RETROSPECTIVE STUDY.

EHA Library, Kyra Velazquez Kennedy, 182677

RISK STRATIFICATION ALGORITHM USING REAL-WORLD DATA FROM PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): DESCRIPTION OF CLINICAL OUTCOME BY TREATMENT REGIMEN

EHA Library, Roman Hájek, 182678

LACK OF CD56 EXPRESSION IN MULTIPLE MYELOMA PATIENTS WITH RISS 2 DISEASE IS ASSOCIATED WITH WORSE PROGNOSIS AND ABOLISHED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Matevz Skerget, 182679

AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA IN GERMANY -REAL-WORLD DATA FROM A NATIONWIDE, MULTI-INSTITUTIONAL SURVEY IN 2015-2016

EHA Library, Maximilian Merz, 182680

MODIFIED HYPERCVAD VERSUS BORTEZOMIB-HYPERCVAD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Emma Scott, 182681

EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE FROM TURKEY

EHA Library, Guray Saydam, 182682

OPTIMIZING THE MANAGEMENT OF NON-HEMATOLOGICAL ADVERSE EFFECTS RELATED TO LENALIDOMIDE IN RELAPSED MULTIPLE MYELOMA PATIENTS. ONE CENTER EXPERIENCE.

EHA Library, María , 182683

PROLONGED THROMBOPROPHYLAXIS IN PATIENTS TREATED WITH LENALIDOMIDE AND DEXAMETHASONE DOES NOT SEEM STRICTLY MANDATORY TO PREVENT LATE THROMBOTIC EVENTS

EHA Library, Cartia Claudio Salvatore, 182684

ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE REAL WORLD

EHA Library, Etsuko Yamazaki, 182685

RETROSPECTIVE ANALYSIS OF 121 MULTIPLE MYELOMA PATIENTS USING THE R-ISS PROGNOSTIC STAGING SYSTEM AND RESPONSE TO FIRST LINE OF TREATMENT

EHA Library, Rasha Ghonema, 182686

FEASIBILITY/PHASE II STUDY OF MYELOABLATIVE BEAM ALLOGENEIC TRANSPLANTATION FOLLOWED BY ORAL IXAZOMIB MAINTENANCE THERAPY IN PATIENTS WITH HIGH RISK MYELOMA

EHA Library, Emma Scott, 182687

EPIDEMIOLOGY OF MULTIPLE MYELOMA. THE GRANADA MYELOMA REGISTRY

EHA Library, Rafael Rios-Tamayo, 182688

REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, Monica Ziff, 182689

EFFICACY AND TOLERABILITY OF LENOLIDOMIDE AND POMALIDOMIDE IN RELAPSED/REFRACTORY MYELOMA PATIENTS IN A REAL WORLD STUDY

EHA Library, George Adams, 182690

APPLICATION OF CONDITIONING REGIMEN WITH BUSULFAN AND CYCLOPHOSPHAMIDE IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

EHA Library, Chengcheng Fu, 182691

MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT, 12 CASES AND REVIEW OF THE LITERATURE

EHA Library, Gergely Varga, 182692

DARATUMUMAB; CHALLENGES OF INTEGRATING THIS NEW THERAPY INTO STANDARD CARE.

EHA Library, Linda Little, 182693

MULTIPLE MYELOMA IN HIV+ PATIENTS LITERATURE REVIEW AND OWN CASE

EHA Library, alexis leyghton, 182694

OPTIMIZATION OF APPROACHES FOR STEM CELL MOBILIZATION FOR AUTOLOGOUS STEM CELL TRANSPLANT FOR MULTIPLE MYELOMA: PRACTICAL CONSIDERATIONS

EHA Library, Oi-Lin Lee, 182695

MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA PATIENTS BY FLOW CYTOMETRY: A SINGLE CENTER EXPERIENCE

EHA Library, Svetlana Sizikova, 182696

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY MULTIPLE MYELOMA PATIENTS

EHA Library, Michela Staderini, 182697

EVOLUTION IN THE INCIDENCE OF MONOCLONAL GAMMOPATHIES IN A SOUTHERN SPAIN TERTIARY HOSPITAL IN THE LAST THIRTEEN YEARS

EHA Library, Jose Maria Maesa, 182698

CHARACTERIZATION OF A SERIES OF PATIENTS WITH PLASMA CELL LEUKEMIA

EHA Library, Pedro Bettencourt Medeiros, 182699

OPTIMIZATION OF POMALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN REFRACTORY/RELAPSED MYELOMA MULTIPLE PATIENTS.

EHA Library, Dunia De Miguel Llorente, 182700

PROGNOSTIC SIGNIFICANCE OF PLASMABLASTIC PLASMA CELLS IN THE ERA OF NOVEL AGENTS IN MULTIPLE MYELOMA

EHA Library, Antoine Machet, 182701

INTERNATIONAL OPPORTUNITIES TO COMPARE ‘REAL WORLD’ DATA FROM MYELOMA REGISTRIES: BASELINE CHARACTERISTICS, FIRST-LINE THERAPIES AND EARLY OUTCOMES FROM AUSTRIA AND AUSTRALIA/NEW ZEALAND

EHA Library, Krystal Bergin, 182702

DETECTING EARLY RELAPSE IN MULTIPLE MYELOMA (MM) AFTER ASCT: USEFULNESS OF IMMUNEASSAYS.

EHA Library, Marcio Andrade-Campos, 182703

EARLY MORTALITY (<6 M) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: COMPREHENSIVE INTERVENTION

EHA Library, Violeta Martinez-Robles, 182704

FIRST LINE USE OF NOVEL AGENTS BEFORE AUTOLOGOUS SCT HAS A POSITIVE IMPACT ON TIME TO SECOND PROGRESSION AND SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA UNDER 70 YEARS.

EHA Library, Susanna Gassiot, 182705

SAFETY AND EFFICACY OF NOVEL AGENTS IN VERY ELDERLY MULTIPLE MYELOMA PATIENTS (AGED 80 YEARS OR MORE): A REPORT BY THE RETE EMATOLOGICA PUGLIESE (REP)

EHA Library, Nicola Sgherza, 182706

BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Min Kyoung KIm, 182707

EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF MULTIPLE MYELOMA IN HIV-POSITIVE PATIENTS - A CASE-SERIES

EHA Library, Ljubinka Nikolic, 182708

FEASIBILITY OF USING GLOBAL FDG UPTAKE IN BONE MARROW TO ASSESS TREATMENT RESPONSE IN MULTIPLE MYELOMA.

EHA Library, Brian Østergaard, 182709

VALUE OF MYELOMA PROGNOSTIC INDICES IN ERA OF NOVEL DRUGS IN TRANSPLANT SETTING

EHA Library, Viktor Zatezalo, 182710

WHICH ORGAN SHOULD WE BIOPSY TO DIAGNOSE AL AMYLOIDOSIS ?

EHA Library, Laura Llorente, 182711

A COMPARISON OF CYCLOPHOSPHAMIDE-GLUCOCORTICOIDS AND LENALIDOMIDE-DEXAMETHASONE AS TREATMENT FOR MULTIPLE MYELOMA IN FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Russell Sterrett, 182712

CLINICAL IMPACT OF THE PLASMA LENALIDOMIDE CONCENTRATION AND THE ANALYSIS OF ANTI-TUMOR IMMUNE RESPONSE IN NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE AND DEXAMETHASONE THERAPY

EHA Library, Takahiro Kobayashi, 182713

THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maiia Soloveva, 182714

BENDAMUSTINE-BORTEZOMIB-DESAMETASONE (BVD) IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Claudio Cerchione, 182715

VE-CADHERIN IN MULTIPLE MYELOMA: AN INDEPENDENT PROGNOSTIC FACTOR FOR PROGRESSION-FREE SURVIVAL

EHA Library, Boris Samura, 182716

THE UTILITY OF FACS PURIFICATION OF PLASMA CELLS FOR FISH ANALYSIS IN MONOCLONAL GAMMOPATHIES

EHA Library, Marta Pereira, 182717

CLINICAL SPECTRUM AND EVOLUTION OF MONOCLONAL GAMMOPATHY ASSOCIATED NEUROPATHY VERSUS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY PATIENTS

EHA Library, Ja Min Byun, 182718

MOLECULAR GENETIC CRITERIA PREDICTING THE EFFICIENCY OF PERIPHERAL BLOOD HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tetiana , 182719

THE INFLUENCE OF MINIMAL RESIDUAL DISEASE AND TUMOR LOAD ON THE PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS

EHA Library, Andrei Garifullin, 182720

QUALITY OF RESPONSE AS PREDICTOR OF SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN REAL LIFE MULTIPLE MYELOMA PATIENTS IN A SINGLE INSTITUTION

EHA Library, Ana Luisa Pinto, 182721

LEPTOMENINGEAL INFILTRATION SCREENING SHOULD BE PERFORMED IN PATIENTS DIAGNOSED WITH PLASMA CELL LEUKAEMIA.

EHA Library, Maria Queralt Salas Gay, 182722

MANAGEMENT AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA IN REAL-WORLD SETTINGS IN BULGARIA, CROATIA AND SLOVAKIA

EHA Library, Georgi Mihaylov, 182723

SINGLE SHOT MEDIUM DOSE MELPHALAN IN RELAPSED MM PATIENTS: A RETROSPECTIVE, SINGLE CENTER EXPERIENCE

EHA Library, Cristina Clissa, 182724

LENALIDOMIDE AT THE DOSE OF TWENTY-FIVE MG EVERY OTHER DAY IN PATIENTS AFFECTED BY MULTIPLE MYELOMA AND RENAL FAILURE : A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 182725

A FEASIBILITY-STUDY ON IMPLEMENTATION OF THE INTERNATIONAL MYELOMA WORKING GROUP RECCOMENDATIONS FOR MULTIPLE MYELOMA PATIENTS IN ROUTINE CLINICAL PRACTICE: A PERIPHERAL CENTER EXPERIENCE

EHA Library, Martina Torchio, 182726

NOCARDIOSIS PROVOKED BY NOVEL AGENTS AT RELAPSED MULTIPLE MYELOMA:CASE SERİES

EHA Library, Zahit Bolaman, 182727

LENALIDOMIDE IN PATIENTS WITH DIALYSIS-DEPENDENT END STAGE RENAL FAILURE (ESRF) AND MULTIPLE MYELOMA

EHA Library, Pietro , 182728

STUDY USE OF 18-F FDG PET / CT SCANNING INTO THE FIRST FOLLOW UP OF PATIENTS WITH MULTIPLE MYELOMA AND ASSOCIATION WITH BIOCHEMICAL RESPONSE

EHA Library, Karla Vallejo Luna, 182729

MULTIPLE MYELOMA IN BORNEO SARAWAK: A DEVELOPING WORLD’S EXPERIENCE

EHA Library, Tze Shin Leong, 182730

A RETROSPECTIVE AND PROSPECTIVE AUDIT OF RADIOLOGICAL INVESTIGATIONS FOR SUSPECTED CASES OF PLASMA CELL DYSCRASIAS/MYELOMA IN THE ALTNAGELVIN AREA HOSPITAL

EHA Library, Gavin Baker, 182731

TONI DEBRE FANCONI SYNDROME DURING MYELOMA, ABOUT 8 CASES

EHA Library, Cherif Rahali, 182732

DEPP RESPONCES WITH CARLFIZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRATORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

EHA Library, Vincenzo Pavone, 182733

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE

EHA Library, Claudio Cerchione, 182734

IMWG ´14 DIAGNOSTIC CRITERIA TO INITIATE TREATMENT IN NEW DIAGNOSED MULTIPLE MYELOMA (NDMM): REAL-WORLD STADISTICS

EHA Library, FERNANDO ESCALANTE BARRIGON, 182735

POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE: A CHANCE FOR RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM). A REVIEW OF A CASE SERIES DIAGNOSED IN A SINGLE CENTER

EHA Library, Ángela Gil, 182736

ROUTINE SCREENING FOR KIT M541L IS NOT WARRANTED IN THE DIAGNOSTIC WORK UP OF PATIENTS WITH HYPEREOSINOPHILIA

EHA Library, Nick Cross, 182737

MUTATIONS OF THE JAK2 GENE AND CYTOGENETIC ABNORMALITIES ARE PREDICTIVE OF PROGRESSION TO HEMATOLOGICAL NEOPLASMS IN PATIENTS WITH IDIOPATHIC LEUKOCYTOSIS

EHA Library, Naoki Mori, 182738

EVALUATION OF EXPRESSION OF MIRNAS ISOLATED MICROVESICLES OF PATIENTS WITH MYELOFIBROSIS ASSOCIATED WITH DISEASE

EHA Library, Cintia Mascarenhas, 182739

COMPREHENSIVE STUDY OF BCR/ABL GENE EXPRESSION IN PROGRESSION OF “CLASSIC” MYELOPROLIFERATIVE DISORDERS

EHA Library, Laura Kesaeva, 182740

IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS.

EHA Library, Süheyla Uyar Bozkurt, 182741

THE HIF1A/2A MRNA INDEX HAS A SIMILAR TREND AS THE CHANGES OF EXPRESSION MRNA CALR AND MDR1 GENES IN WHOLE BLOOD SAMPLES OF PATIENTS WITH JAK2 V617F POSITIVE MPN

EHA Library, Marina Stolyar, 182742

CD177 EXPRESSION IN PERIPHERAL BLOOD NEUTROPHILS IN HEALTH AND DISEASE STATES

EHA Library, Aya Arafat, 182743

DETECTION OF THE MUTATIONS IN GENES JAK2 AND MPL IN THE DIAGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS

EHA Library, Abdukadir boboev, 182744

ASSOCIATION OF MYELOPROLIFERATIVE NEOPLASM AND LYMPHOPROLIFERATIVE DISORDER IN 3 PATIENTS

EHA Library, Barbara Foucher, 182745

CLINICAL AND ANALYTICAL DIFFERENCES BETWEEN CALR TYPE-1 AND CALR TYPE-2 MUTATION IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS: A SINGLE CENTER STUDY

EHA Library, Marta Sobas, 182746

ESSENTIAL TRHOMBOCYTHEMIA: STUDY OF TREATMENT LINES REQUIRED. EXPERIENCE OF A SINGLE CENTER

EHA Library, Mercedes Berenguer, 182747

THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Anastasiia Zherniakova, 182748

DETECTION OF JAK2 EXON 12 MUTATIONS BY HETERODUPLEX ANALYSIS AND PYROSEQUENCING

EHA Library, Tatiana Subbotina, 182749

INTRODUCTION OF AN NGS GENE PANEL INTO CLINICAL SERVICE FOR MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Anna Skowronska, 182750

IN JAK2V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS, BLEEDING RISK CORRELATES WITH ALLELE BURDEN

EHA Library, Irene Bertozzi, 182751

JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Mariasanta Napolitano, 182752

COMPARISON OF CLINICAL AND LABORATORY DATA, INCLUDING JAK-2 46/1 HAPLOTYPE, BETWEEN PATIENTS WITH IDIOPATHIC ERYTHROCYTOSIS AND POLYCYTHEMIA VERA.

EHA Library, Mariasanta Napolitano, 182753

LABORATORY RESPONSIVENESS OF LOW-DOSE ASPIRIN IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Rossella Cacciola, 182754

CLINICAL AND EXPERIMENTAL CHARACTERISTICS OF MYELOID/LYMPHOID NEOPLASMS DISPLAYING PDGFRA OR PDGFRB REARRANGEMENT

EHA Library, Huiying Qiu, 182755

PLATELET AGGREGATION STUDY OF ESSENTIAL THROMBOCYTHEMIA TREATED WITH ANAGRELIDE

EHA Library, Yasushi Hiramatsu, 182756

A SINGLE CENTRE EXPERIENCE OF MASTOCYTOSIS

EHA Library, Gulkan Ozkan, 182757

JAK2 PSEUDO-KINASE AND KINASE MUTATIONS IN THE ETIOLOGY OF THROMBOCYTOSIS

EHA Library, Margarida Coucelo, 182758

COMPARISONS OF PATIENT MANAGEMENT IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY

EHA Library, Claire Harrison, 182759

ANALYSIS OF EMERGING MOLECULAR SIGNATURES IN MPNANALYSIS OF EMERGING MOLECULAR SIGNATURES AND ASSOCIATED CLINICAL FEATURES IN MPN

EHA Library, Salem H Al, 182760

IMPACT OF THE TYPE OF CALR MUTATIONS ON THE CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTHEMIA AND PRIMARY MYELOFIBROSIS

EHA Library, Ekaterina Lisina, 182761

THE UNIQUE CASE OF GERMLINE CEBPA MUTATION IN PATIENT WITH FIP1L1/PDGFRA ASSOCIATED MYELOID/LYMPHOID NEOPLASM WITH EOSINOPHILIA

EHA Library, Nelli Gabeeva, 182763

DEVELOPMENT AND DESIGN OF A RANDOMIZED CONTROLLED TRIAL USING ONLINE YOGA FOR SYMPTOM MANAGEMENT IN MYELOPROLIFERATIVE NEOPLASM PATIENTS

EHA Library, Jennifer Huberty, 182764

COMPARISONS OF SYMPTOM BURDEN IN MYELOPROLIFERATIVE NEOPLASM PATIENTS IN THE UK VS REST OF WORLD: ANALYSIS FROM THE INTERNATIONAL LANDMARK SURVEY

EHA Library, Claire Harrison, 182765

MPN10 SCORE AND SURVIVAL OF MOLECULARLY ANNOTATED MYELOPROLIFERATIVE NEOPLASMS (MPNS) PATIENTS; A FIRST REPORT ON AN EGYPTIAN COHORT

EHA Library, Yasser Elnahass, 182766

FINAL RESULTS FROM PEN-PV STUDY, A SINGLE-ARM PHASE 3 TRIAL ASSESSING THE EASE OF SELF-ADMINISTRATING ROPEGINTERFERON ALFA-2B USING A PRE-FILLED PEN IN POLYCYTHEMIA VERA PATIENTS

EHA Library, Heinz Gisslinger, 182767

JAK2, CALR AND MPL MUTATIONS: CORRELATION WITH PHENOTIPE DISEASE AND HISTOPATHOLOGICAL FEATURES OF BONE BIOPSY

EHA Library, Heidy , 182768

CLINICAL IMPLICATION OF QUANTITATIVE JAK2 V617F ANALYSIS WITH DROPLET DIGITAL PCR IN MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Eunyoung Lee, 182769

CLINICAL IMPACT OF JAK2 AND CARLETICULIN GENE MUTATIONS ON PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Mariasanta Napolitano, 182770

RUXOLITINIB IN MYELOFIBROSIS: A MULTICENTRE EXPERIENCE FROM THE EAST OF ENGLAND

EHA Library, James Russell, 182771

MONITORING OF TRANSIENT MYELOPROLIFERATIVE DISORDER AND LEUKEMIA IN DOWN’S SYNDROME : A SINGLE UNIVERSITY HOSPITAL STUDY

EHA Library, Jun Eun Park, 182772

INFECTIOUS EVENTS IN A COHORT OF PATIENTS WITH MYELOFIBROSIS UNDER TREATMENT COMPARING RUXOLITINIB WITH CONVENTIONAL THERAPY. A MONOCENTRIC EXPERIENCE OF 22 PATIENTS RETROSPECTIVELY ANALYSED.

EHA Library, Lorenza Torti, 182773

THE JAK2V617F MUTATION AND LEUKOCYTOSIS AS RISK FACTORS FOR INCIDENCE OF THROMBOTIC COMPLICATIONS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Evica Simonovic, 182774